What is the level of liabilities of Pulmonx this year?
Pulmonx has a debt balance of 77.04 M USD this year.
Pulmonx Liabilities 2025
Pulmonx Liabilities
77.04 M USD
Ticker
LUNG
ISIN
US7458481014
WKN
A2P1AF
In 2025, Pulmonx's total liabilities amounted to 77.04 M USD, a 29.55% difference from the 59.47 M USD total liabilities in the previous year.
Pulmonx Aktienanalyse
What does Pulmonx do?
Pulmonx Corp is an innovative medical technology company based in the USA and Europe. The company specializes in the development of non-invasive solutions for the treatment of lung diseases. Pulmonx was founded in 1997 and has since introduced numerous groundbreaking technologies to the market that improve the quality of life for patients with chronic lung diseases. Pulmonx ist eines der beliebtesten Unternehmen auf Eulerpool.com.Liabilities Details
Assessing Pulmonx's Liabilities
Pulmonx's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Pulmonx's financial stability, operational efficiency, and long-term viability.
Year-to-Year Comparison
By comparing Pulmonx's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.
Impact on Investments
Pulmonx's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.
Interpreting Liability Fluctuations
Shifts in Pulmonx’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.
Frequently Asked Questions about Pulmonx stock
What were the liabilities of Pulmonx compared to the previous year?
The liabilities of Pulmonx have increased by 29.55% increased compared to the previous year.
What are the consequences of high debt for investors of Pulmonx?
High liabilities can pose a risk for investors of Pulmonx, as they can weaken the company's financial position and impair its ability to meet its obligations.
What consequences do low liabilities have for investors in Pulmonx?
Low liabilities mean that Pulmonx has a strong financial position and is able to meet its obligations without overburdening its finances.
How does an increase in liabilities of Pulmonx affect the company?
An increase in liabilities of Pulmonx can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.
How does a reduction in the liabilities of Pulmonx affect the company?
A decrease in the liabilities of Pulmonx can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.
What are some factors that influence the liabilities of Pulmonx?
Some factors that can influence the liabilities of Pulmonx include investments, acquisitions, operating costs, and sales development.
Why is the level of liabilities of Pulmonx so important for investors?
The liabilities of Pulmonx are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.
What strategic measures can Pulmonx take to modify the liabilities?
To change its liabilities, Pulmonx can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.
How much dividend does Pulmonx pay?
Over the past 12 months, Pulmonx paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Pulmonx is expected to pay a dividend of 0 USD.
What is the dividend yield of Pulmonx?
The current dividend yield of Pulmonx is .
When does Pulmonx pay dividends?
Pulmonx pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Pulmonx?
Pulmonx paid dividends every year for the past 0 years.
What is the dividend of Pulmonx?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Pulmonx located?
Pulmonx is assigned to the 'Health' sector.
Wann musste ich die Aktien von Pulmonx kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Pulmonx from 10/9/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/9/2025.
When did Pulmonx pay the last dividend?
The last dividend was paid out on 10/9/2025.
What was the dividend of Pulmonx in the year 2024?
In the year 2024, Pulmonx distributed 0 USD as dividends.
In which currency does Pulmonx pay out the dividend?
The dividends of Pulmonx are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Pulmonx
Our stock analysis for Pulmonx Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Pulmonx Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
